JP2021505568A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021505568A5 JP2021505568A5 JP2020530502A JP2020530502A JP2021505568A5 JP 2021505568 A5 JP2021505568 A5 JP 2021505568A5 JP 2020530502 A JP2020530502 A JP 2020530502A JP 2020530502 A JP2020530502 A JP 2020530502A JP 2021505568 A5 JP2021505568 A5 JP 2021505568A5
- Authority
- JP
- Japan
- Prior art keywords
- methyl
- hydrogen
- membered
- optionally
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1720189.8 | 2017-12-04 | ||
| GBGB1720189.8A GB201720189D0 (en) | 2017-12-04 | 2017-12-04 | Dopamine-B-hydroxylase inhibitors |
| GB1804439.6 | 2018-03-20 | ||
| GBGB1804439.6A GB201804439D0 (en) | 2018-03-20 | 2018-03-20 | Dopamin-b-hydroxylase inhibitors |
| PCT/PT2018/050043 WO2019112457A1 (en) | 2017-12-04 | 2018-11-30 | Dopamine-β-hydroxylase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021505568A JP2021505568A (ja) | 2021-02-18 |
| JP2021505568A5 true JP2021505568A5 (cg-RX-API-DMAC10.html) | 2022-01-11 |
| JP7167155B2 JP7167155B2 (ja) | 2022-11-08 |
Family
ID=65012066
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020530502A Expired - Fee Related JP7167155B2 (ja) | 2017-12-04 | 2018-11-30 | ドーパミン-β-ヒドロキシラーゼ阻害剤 |
Country Status (16)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019112457A1 (en) | 2017-12-04 | 2019-06-13 | BIAL - PORTELA & Cª, S.A. | Dopamine-β-hydroxylase inhibitors |
| GB201908044D0 (en) | 2019-06-05 | 2019-07-17 | Bial Portela & Ca Sa | Dopamine-B-Hydroxylase inhibitors |
| TW202528310A (zh) * | 2023-09-20 | 2025-07-16 | 美商深蘋果治療股份有限公司 | 經取代胺化合物,組合物及使用方法 |
| WO2025161144A1 (zh) * | 2024-01-29 | 2025-08-07 | 上海深势唯思科技有限责任公司 | 芳基杂环类Kv1.3抑制剂及其制备方法和用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3647790A (en) | 1969-04-08 | 1972-03-07 | American Home Prod | Ouinoxalinyl-oxazolidines and -oxazines |
| FR2449689A1 (fr) | 1979-02-20 | 1980-09-19 | Logeais Labor Jacques | Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique |
| US4628059A (en) | 1985-10-31 | 1986-12-09 | Smithklein Beckman Corporation | Dopamine-β-hydroxylase inhibitors |
| ES2201104T3 (es) | 1994-04-26 | 2004-03-16 | Roche Palo Alto Llc | Derivados de benzociclohexilimidazoltiona. |
| US6482982B1 (en) | 2001-03-09 | 2002-11-19 | University Of Sciences Of Philadelphia | Halogenated antituberculosis agents |
| IL143379A (en) * | 2001-05-24 | 2013-11-28 | Yissum Res Dev Co | Oligonucleotide against human ache isoform r and its uses |
| US7125904B2 (en) * | 2002-10-11 | 2006-10-24 | Portela & C.A., S.A. | Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation |
| WO2008085008A1 (en) * | 2007-01-11 | 2008-07-17 | Mogam Biotechnology Research Institute | T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases |
| GB0708818D0 (en) * | 2007-05-08 | 2007-06-13 | Portela & Ca Sa | Compounds |
| NZ583193A (en) | 2007-07-23 | 2012-05-25 | Biotie Therapies Inc | Treatment of post-traumatic stress disorder with nepicastat |
| US8110578B2 (en) * | 2008-10-27 | 2012-02-07 | Signal Pharmaceuticals, Llc | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway |
| US20150376198A1 (en) | 2013-02-18 | 2015-12-31 | The Scripps Research Institute | Modulators of vasopressin receptors with therapeutic potential |
| JOP20190049A1 (ar) | 2016-09-23 | 2019-03-20 | Bial Portela & C? S A | مثبطات دوبامين-b-هيدروكسيلاز |
| WO2019112457A1 (en) | 2017-12-04 | 2019-06-13 | BIAL - PORTELA & Cª, S.A. | Dopamine-β-hydroxylase inhibitors |
-
2018
- 2018-11-30 WO PCT/PT2018/050043 patent/WO2019112457A1/en not_active Ceased
- 2018-11-30 EP EP18833340.5A patent/EP3720856A1/en not_active Withdrawn
- 2018-11-30 CA CA3082337A patent/CA3082337A1/en active Pending
- 2018-11-30 SG SG11202004231YA patent/SG11202004231YA/en unknown
- 2018-11-30 AU AU2018379646A patent/AU2018379646A1/en not_active Abandoned
- 2018-11-30 BR BR112020010216-4A patent/BR112020010216A2/pt not_active IP Right Cessation
- 2018-11-30 CN CN201880080871.5A patent/CN111479812A/zh active Pending
- 2018-11-30 RU RU2020121820A patent/RU2020121820A/ru unknown
- 2018-11-30 MX MX2020005864A patent/MX2020005864A/es unknown
- 2018-11-30 JP JP2020530502A patent/JP7167155B2/ja not_active Expired - Fee Related
- 2018-11-30 US US16/769,045 patent/US11434242B2/en active Active
- 2018-11-30 TW TW107143059A patent/TW201925193A/zh unknown
- 2018-11-30 KR KR1020207019157A patent/KR20200096584A/ko not_active Withdrawn
-
2020
- 2020-05-10 IL IL274550A patent/IL274550B2/en unknown
- 2020-06-01 CL CL2020001461A patent/CL2020001461A1/es unknown
- 2020-06-02 PH PH12020500542A patent/PH12020500542A1/en unknown
-
2022
- 2022-09-01 US US17/901,007 patent/US20230138795A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20201641T1 (hr) | Novi spojevi i njihove farmaceutske kompozicije za liječenje inflamatornih poremećaja | |
| ES2629414T3 (es) | Derivados de tiazol | |
| JP2016523911A5 (cg-RX-API-DMAC10.html) | ||
| JP2023071767A (ja) | Brm標的化化合物および関連使用方法 | |
| ES2901197T3 (es) | Moduladores alostéricos de los receptores nicotínicos de la acetilcolina | |
| JP5911638B2 (ja) | ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用 | |
| JP2009529047A5 (cg-RX-API-DMAC10.html) | ||
| RU2016102137A (ru) | Первичные карбоксамиды в качестве ингибиторов bik | |
| CA2831966C (en) | Thiazole derivatives | |
| RU2665036C2 (ru) | Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения | |
| HRP20200781T1 (hr) | DERIVATI PIRAZOLO[1,5-a]PIRAZIN-4-ILA KAO INHIBITORI JAK | |
| JP2018501315A5 (cg-RX-API-DMAC10.html) | ||
| JP2020536116A5 (cg-RX-API-DMAC10.html) | ||
| MX2008013400A (es) | Derivado de azolcarboxamida. | |
| IL274550B2 (en) | Dopamine-b-hydroxylase inhibitors | |
| JP2017531039A5 (cg-RX-API-DMAC10.html) | ||
| JP2013519724A5 (cg-RX-API-DMAC10.html) | ||
| AU2012342891B2 (en) | 3-Cyanoaryl-1H-pyrrolo[2.3-b]pyridine derivatives | |
| RU2015137103A (ru) | Фуропиридины в качестве ингибиторов бромодоменов | |
| HRP20121069T1 (hr) | Supstituirani derivati amida kao inhibitori protein kinaze | |
| RU2012126083A (ru) | Производные аминооксазина | |
| CN101605540A (zh) | 使用mek抑制剂的方法 | |
| RU2017118165A (ru) | Ингибиторы энхансера гомолога 2 zestes | |
| JP2009515814A5 (cg-RX-API-DMAC10.html) | ||
| JP2016503785A5 (cg-RX-API-DMAC10.html) |